Johanna Midelet
Director Bioconjugation and Chemistry Abzena
Seminars
Thursday 11th June 2026
Driving Innovation in ADC Development with ThioBridge® Conjugation & Linker Technology
9:30 am
- Assessing the role of linker architecture as a key element of ADC design
- Discussion of ThioBridge® as a Next-Generation, site-specific conjugation technology for modulation of DAR and production of homogeneous ADCs
- Supporting characterization and manufacture of bioconjugates through Abzena’s integrated offering
